Protalix BioTherapeutics (PLX) EBT Margin Growth (3y) (2013 - 2026)
Protalix BioTherapeutics (PLX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
9,326.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
9,326.00 |
| Dec 31, 2025 |
-382.00 |
| Sep 30, 2025 |
3,769.00 |
| Jun 30, 2025 |
6,516.00 |
| Mar 31, 2025 |
-2,269.00 |
| Dec 31, 2024 |
14,249.00 |
| Sep 30, 2024 |
5,703.00 |
| Jun 30, 2024 |
16,003.00 |
| Mar 31, 2024 |
-7,451.00 |
| Dec 31, 2023 |
-21,194.00 |
| Sep 30, 2023 |
2,560.00 |
| Jun 30, 2023 |
9,420.00 |
| Mar 31, 2023 |
-3,738.00 |
| Dec 31, 2022 |
-3,805.00 |
| Sep 30, 2022 |
7.00 |
| Jun 30, 2022 |
231.00 |
| Mar 31, 2022 |
5,719.00 |
| Dec 31, 2021 |
23,773.00 |
| Sep 30, 2021 |
80,177.00 |
| Jun 30, 2021 |
24,868.00 |
